Project Grant P01MH139132
- The National Institute of Mental Health awarded Indiana University Indianapolis $667,598 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a pilot randomized controlled trial evaluating CAMS-4TEENS, an evidence-based suicide-specific treatment adapted for adolescents involved in the juvenile justice system. The award funds two primary research aims. Aim 1 establishes the feasibility and acceptability of a pilot RCT comparing CAMS-4TEENS to enhanced...
- The National Institute of Mental Health awarded Trustees of Indiana University $2.938 million on September 24, 2025, under the Mental Health Research Grants program (CFDA 93.242) to investigate maternal depression trajectories across 25 years in relation to sociocultural risk factors and a randomized parenting intervention. The recipient will examine variation in depression trajectories among low-income mothers across two decades, prospectively analyzing how sociodevelopmental characteristics,...
- The National Institute of Mental Health awarded the University of Texas at Austin $1.633 million on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to establish and operate an administrative research core supporting the Early Psychosis Intervention Network in Texas (EPINET-TX), a learning health system focused on coordinated specialty care for individuals experiencing early psychosis. The award funds development of standardized data collection systems,...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded Mental Health Association In Indiana Inc. $146,553 on September 30, 2026, under the Center for Mental Health Services Projects of Regional and National Significance program (CFDA 93.532). Project C.O.R.E. (Capacity, Operations, & Recovery Enhancement) will strengthen Indiana's statewide mental health peer workforce and peer-run organization infrastructure over three years through...
- The National Institute of Mental Health awarded Ividence Inc. $315,276 on August 5, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop a federated causal inference framework for evaluating the mental health effects of glucagon-like peptide-1 receptor agonists (GLP-1 RAs). The project will produce a privacy-preserving, multi-site analytical framework and accompanying R software package to generate real-world evidence on neuropsychiatric outcomes from GLP-1 RA...
- The National Institute of Mental Health awarded Beth Israel Deaconess Medical Center, Inc. $2.961 million on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop standardized digital health data formats for mental health research and clinical care. The award funds five integrated aims. Aim 1 establishes a multidisciplinary consortium of clinicians, researchers, industry representatives, regulators, and patient advocates to develop a governance framework...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded $545,000 to Trustees of Indiana University (Indiana University Indianapolis) on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) to sustain and expand comprehensive treatment and recovery services for Indiana adolescents and young adults with substance use disorders, including those with co-occurring...
- The National Institute of Mental Health awarded the Trustees of Indiana University $436,006 on September 1, 2026, to investigate circuit operation underlying fear memory processes in the amygdala under the Mental Health Research Grants program (CFDA 93.242). The award funds research into the neural mechanisms regulating defensive behaviors and fear memory formation in the amygdala. Current models posit that the lateral amygdala serves as the primary input site for sensory information during fear...
- The National Institute of Mental Health awarded the University of Illinois $100,228 on September 30, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct qualitative research on implementation of suicide prevention evidence-based practices in outpatient pediatric behavioral health settings. The recipient will recruit pediatric mental health clinicians, youth patients ages 12–18, and patient caregivers from public outpatient child psychiatry clinics to participate in...
- The National Institute of Nursing Research awarded the Trustees of Indiana University (Indiana University Indianapolis) $803,850 on September 19, 2025, under the Nursing Research program (CFDA 93.361) to develop and implement the Midwest Leadership in Education, Application, and Dissemination of Research on the Social Determinants of Health (LEADRS) program. The program provides rigorous training to nurse scientists and aligned health professionals in conceptual frameworks, research methods, and...
The National Institute of Mental Health awarded Indiana University Indianapolis $1.632 million on August 12, 2026, under the Mental Health Research Grants program (CFDA 93.242) to establish and operate Academic-Community EPINET, a learning healthcare system network designed to enhance outcomes in early psychosis care through improved stress tolerance and continuous quality improvement. The award funds a network of six early intervention clinical spoke sites connected through advanced informatics to a central hub at Indiana University Indianapolis. The project implements a learning healthcare system that embeds data collection and performance measurement into routine clinic workflows using the EPINET Common Assessment Battery and the CSC-HONE informatics platform. The system consolidates electronic health records data to enable real-time outcome comparisons across sites, identify performance gaps, and drive continuous quality improvement aligned with international best practice standards while maintaining privacy protections. In a second phase, the project expands the learning healthcare system by integrating community partners with lived experience in early psychosis into a quality improvement incubator to enhance care outcomes. The six clinical spoke sites operate established early intervention programs following the Coordinated Specialty Care model and bring deep expertise in data collection, assessments, and clinical trial research. Performance occurs in Indianapolis, Indiana, with a period of performance through May 31, 2030. The assistance type is a Project Grant.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.6m | 8/14/26 |